Latest filing published 06 Jun 2025 for NovoCure Ltd. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Gabriel Leung is a declared insider of Novocure Ltd (senior executive), with filings sourced from SEC (Form 4). Between 15 May 2018 and 4 June 2025, the trades on record add up to 90 filings.
Every open-market trade on record is a sale: 45 sales worth €19.5M. The rest of the record consists of 6 share grants and 39 option exercises. So far in 2025, the count stands at no purchases and 1 sale.
On 6 June 2025 came the latest disclosure, a share grant in Novocure Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations